Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519 - PubMed (original) (raw)
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519
Anthony J Williams et al. Stroke. 2004 May.
Abstract
Background and purpose: Clinical development of novel neuroprotection therapies for the treatment of brain injury has been unsuccessful. One critical limitation is the lack of a viable therapeutic treatment window (TW). In this study, we evaluated the neuroprotection TW for the proteosome inhibitor MLN519 after ischemia/reperfusion brain injury in rats as related to its antiinflammatory mechanism.
Methods: Male Sprague-Dawley rats were subjected to 2 hours of middle cerebral artery occlusion (MCAo), followed by 70 hours of reperfusion and recovery. MLN519 was administered after injury (starting 6 to 12 hours after MCAo) to evaluate the full TW. Brain infarction, neuronal degeneration, neurological recovery, leukocyte infiltration, and inflammatory gene mRNA levels were assessed.
Results: Core infarct volume in vehicle-treated rats (216+/-25 mm3) was reduced with delayed MLN519 treatments of 6, 8, or 10 hours after injury (45+/-13, 86+/-28, and 150+/-27 mm3, respectively, P<0.05) and was associated with reductions in neuronal and axonal degeneration. MLN519-treated rats had reduced brain mRNA levels of TNF-alpha (46%, P<0.05), ICAM-1 (58%, P<0.05), IL-6 (58%, P<0.05), and E-selectin (72%, P<0.05) at 24 hours after injury. Furthermore, MLN519 treatment reduced leukocyte infiltration by 32% to 80% (P<0.05) in ischemic brain regions.
Conclusions: Neuroprotection treatment with MLN519 provides an extended TW of up to 10 hours after ischemia/reperfusion brain injury, in part by attenuating the inflammatory response. As such, the delayed onset of brain inflammation after an ischemic injury offers a prime target for extending the neuroprotective TW with compounds such as MLN519, used either alone or possibly as an adjunctive therapy with thrombolytic agents.
Similar articles
- Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat.
Berti R, Williams AJ, Velarde LC, Moffett JR, Elliott PJ, Adams J, Yao C, Dave JR, Tortella FC. Berti R, et al. Neurotox Res. 2003;5(7):505-14. doi: 10.1007/BF03033160. Neurotox Res. 2003. PMID: 14715434 - Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration.
Williams AJ, Dave JR, Tortella FC. Williams AJ, et al. Neurochem Int. 2006 Jul;49(2):106-12. doi: 10.1016/j.neuint.2006.03.018. Epub 2006 Jun 8. Neurochem Int. 2006. PMID: 16759750 Review. - The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats.
Xu X, Zhang S, Zhang L, Yan W, Zheng X. Xu X, et al. Planta Med. 2005 Jul;71(7):585-91. doi: 10.1055/s-2005-871261. Planta Med. 2005. PMID: 16041641 - Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon.
Jean WC, Spellman SR, Nussbaum ES, Low WC. Jean WC, et al. Neurosurgery. 1998 Dec;43(6):1382-96; discussion 1396-7. doi: 10.1097/00006123-199812000-00076. Neurosurgery. 1998. PMID: 9848853 Review.
Cited by
- Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window.
Ley JJ, Belayev L, Saul I, Becker DA, Ginsberg MD. Ley JJ, et al. Brain Res. 2007 Nov 14;1180:101-10. doi: 10.1016/j.brainres.2007.05.028. Epub 2007 May 26. Brain Res. 2007. PMID: 17945201 Free PMC article. - Gastrodin alleviates cerebral ischemic damage in mice by improving anti-oxidant and anti-inflammation activities and inhibiting apoptosis pathway.
Peng Z, Wang S, Chen G, Cai M, Liu R, Deng J, Liu J, Zhang T, Tan Q, Hai C. Peng Z, et al. Neurochem Res. 2015 Apr;40(4):661-73. doi: 10.1007/s11064-015-1513-5. Epub 2015 Jan 13. Neurochem Res. 2015. PMID: 25582916 - Ischemic postconditioning protects the neurovascular unit after focal cerebral ischemia/reperfusion injury.
Han D, Zhang S, Fan B, Wen LL, Sun M, Zhang H, Feng J. Han D, et al. J Mol Neurosci. 2014 May;53(1):50-8. doi: 10.1007/s12031-013-0196-0. Epub 2013 Dec 12. J Mol Neurosci. 2014. PMID: 24337985 - Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat.
Williams AJ, Wei HH, Dave JR, Tortella FC. Williams AJ, et al. J Neuroinflammation. 2007 Jul 2;4:17. doi: 10.1186/1742-2094-4-17. J Neuroinflammation. 2007. PMID: 17605820 Free PMC article. - Rodent models of focal stroke: size, mechanism, and purpose.
Carmichael ST. Carmichael ST. NeuroRx. 2005 Jul;2(3):396-409. doi: 10.1602/neurorx.2.3.396. NeuroRx. 2005. PMID: 16389304 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous